JLV Consult
ActiveSummary
JLV Consult has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €348,282 and a net result of €66,892. Equity is growing by about 29% per year across the filed financial years. Its solvency ranks better than 33% of 22,581 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Directors
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| STAQUET Laurent Victor Edouard |
|
Owners and capital
Owners
Owners 0
No owner stated in the accounts, acts or LEI register we read.
Stated earlier (1)
An older source named these owners; newer accounts no longer list them.
-
share not stated
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- STAQUET Laurent Victor Edouard 185 shares
- LAVISTA PHARMA (BE 0816.918.063) 1 share
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 01-12-2023 Converted to unavailable equity